# HX Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hx-diagnostics

- Industry: Healthcare
- Headquarters: Emeryville, US
- Website: www.hxdiagnostics.com
- Total disclosed funding: $7.8M
- Latest round: Series B (Sep 30, 2009)
- Investors on record: 3

## About

HX Diagnostics specializes in innovative diagnostic solutions that enhance health outcomes and streamline patient care through advanced tools tailored for healthcare providers and end-users in various settings.HX Diagnostics is engaged in developing advanced diagnostic solutions aimed at improving health outcomes. The company is headquartered in Emeryville, US. It has completed a total of 3 deals, with its latest funding round being a Series B, which raised USD 4.70 mn from Kleiner Perkins. This round constitutes the total amount raised by the company.HX Diagnostics focuses on delivering a suite of innovative diagnostic solutions aimed at enhancing health outcomes and streamlining patient care. The company develops advanced diagnostic tools designed for healthcare providers and end-users across hospitals, clinics, and laboratories. Their products provide accurate and timely diagnostic results to address critical health issues, facilitating informed medical treatment decisions. HX Diagnostics aims to serve a diverse clientele across North America, Europe, and parts of Asia, with an emphasis on user-friendly interfaces and integration with existing healthcare systems.HX Diagnostics generates revenue through direct-to-consumer sales and partnerships with healthcare institutions. The company engages in B2B transactions by supplying its diagnostic products directly to hospitals and clinics, which utilize the tools for patient care. Specific pricing plans cater to varying scales of healthcare providers, enabling both large institutions and smaller clinics to access their offerings. Revenue is generated from one-time purchases and potential subscription services for regular updates and support, reinforcing ongoing relationships with clients.HX Diagnostics went out of business.

## Funding rounds

- Series B, Sep 30, 2009, $4.7M — Kleiner Perkins
- Series A, Jan 16, 2009, $3.1M — Kleiner Perkins, Nanogen, Xiamen YST Biotech Co.

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series B
- Nanogen — Series A
- Xiamen YST Biotech Co. — Series A